DCC’s long-running misunderstanding with the stock market appeared to continue on Tuesday, when the group delivered the promised disposal of its healthcare division and was rewarded with a share price drop of over 4.5 per cent in the day’s trading. The Dublin-headquartered, London-listed, FTSE 100 company has long baffled equity investors, despite generating profits and dividends like clockwork for decades. A three-legged conglomerate operating across energy, healthcare supplies, and technology, it has never fit neatly in any box.  Was DCC purely a listed investment vehicle like Berkshire Hathaway? A Japanese-style keiretsu with fingers in multiple industrial pies? A future champion…

Read on for just €1

For a limited time, get your first month for €1 and unlock full access to The Currency and The Wall Street Journal – two premium memberships, one subscription.

Subscribe

Cancel at any time.

Are you already a member? .